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Tramadol-loaded interpenetrating polymer network (IPN)
alginate-gelatin (AG) microgels (MG) were prepared by
the chemical cross-linking technique with glutaraldehyde
as cross-linking agent and were optimized using respon-
se surfaces. A central composite design for 2 factors, at 3
levels each, was employed to evaluate the effect of criti-
cal formulation variables, namely the amount of gelatin
(X1) and glutaraldehyde (X2), on geometric mean diame-
ter, encapsulation efficiency, diffusion coefficient (D),
amount of mucin adsorbed per unit mass (Qe) and 50 %
drug release time (t50). Microgels with average particle
size in the range of 44.31–102.41 m were obtained. Drug
encapsulation up to 86.5 % was achieved. MGs were cha-
racterized by FT-IR spectroscopy to assess formation of
the IPN structure and differential scanning calorimetry
(DSC) was performed to understand the nature of drug
dispersion after encapsulation into IPN microgels. Both
equilibrium and dynamic swelling studies were per-
formed in pH 7.4 phosphate buffer. Diffusion coefficients
and exponents for water transport were determined us-
ing an empirical equation. The mucoadhesive properties
of MGs were evaluated in aqueous solution by measur-
ing the mucin adsorbed on MGs. Adsorption isotherms
were constructed and fitted with Freundlich and Lang-
muir equations. In vitro release studies indicated the de-
pendence of drug release on the extent of cross-linking
and the amount of gelatin used in preparing IPNs. The
release rates were fitted to a power law equation and Hi-
guchi’s model to compute the various drug transport pa-
rameters, n value ranged from 0.4055 to 0.5754, suggest-
ing that release may vary from Fickian to quasi-Fickian
depending upon variation in the formulation composition.
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fusion, mucin adsorption
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Naturally occurring polymers, being biocompatible and biodegradable, are current-
ly extensively researched by the pharmaceutical industry for the development of novel
drug delivery systems. Alginate is a water-soluble, naturally occurring polysaccharide
abundantly found in the surface of brown seaweeds (Phaeophyceae, mainly Laminaria).
Alginate beads alone or in combination with other polymers have been extensively stud-
ied by researchers for their diverse pharmaceutical applications, particularly as drug de-
livery system (1–3). Moreover, alginate is reported to be non-toxic and biodegradable
when given orally and to have a protective effect on the mucous membrane of the upper
respiratory tract (4).
Gelatin is a fibrous protein produced by partial hydrolysis of colagen extracted
from the bones, connective tissues, organs, and some intestines of animals such as do-
mesticated cattle and horses. Gelatin in conjunction with alginate (after cross-linking)
may be potentially used for controlling the release of drugs, insecticides, pheromones (5, 6).
In the current study, gelatin is being incorporated in Na-alginate IPN microgels with the
aim to improve the mucoadhesive strength and gel stability of alginate. An interpenetrat-
ing polymer network (IPN) is any material containing two polymers, each in network
form. The advantages of IPN systems are enhancement of the mechanical strength of the
network and increase in the compatibility of polymer blends, which exhibit favorable
properties of phase separated materials (7).
Tramadol hydrochloride is a centrally acting analgesic. The chemical name of tra-
madol hydrochloride is (±) cis-2-[(dimethylamino) methyl]-1-(3-methoxyphenyl) cyclo-
hexanol hydrochloride. Tramadol is marketed as a mixture and the (+)- is approxima-
tely four times more potent than the (–)-enantiomer in terms of m-opioid receptor affinity
and 5-HT reuptake, whereas the (–)-enantiomer is responsible for noradrenaline reup-
take effects (8).
The present study aims to prepare drug-loaded sodium alginate-gelatin IPN micro-
gels by the chemical cross-linking method and to study the effect of gelatin and cross-
-linking agent on release characteristics of the drug. The formulated microgels were ana-
lyzed for particle size, encapsulation efficiency, diffusion coefficient, amount of mucin
adsorbed per unit mass and in-vitro release. Various exponents of swelling, adsorption
and release studies were calculated. Response surface methodology (RSM) is a widely
practiced approach in the development and optimization of drug delivery devices. De-
sign of experiments generates polynomial equations and mapping of the response over
the experimental domain to determine the optimum formulation(s) (9).
EXPERIMENTAL
Materials
Tramadol hydrocloride was received as a gift sample from Indswift Laboratories
Ltd., India and gelatin from Cadila Healthcare Ltd., India. Mucin from porcine stomach
type III (bound sialic acid 0.5–1.5 %) was procured from Sigma Aldrich, USA. Sodium
alginate and glutaraldehyde were procured from Loba Chemie, India. All the reagents
were of analytical grade and were used as received.
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Formulation of sodium alginate-gelatin IPN microgels
Chemical cross-linking technique was used to formulate sodium alginate-gelatin
IPN microgels. Alginate-gelatin solution was prepared in distilled water by gentle heat-
ing. A weighed amount of drug was added to the prepared solution and mixed homoge-
neously using a magnetic stirrer. The polymer solution containing the drug was pre-
heated to 40 °C and then added dropwise, using a syringe fitted with a 24 G needle, into
olive oil (containing a lipophilic surfactant Span 80, 1 %, V/V) at a temperature of 40 °C
under stirring using a mixer with a marine impeller. A 15-mL volume of acetone was
then added and the mixture was further stirred for 30 min. The microgels were then
cross-linked with glutaraldehyde solution in acetone/0.01 mol L–1 HCl solution (7:3) for
a predetermined time. The mixture was then centrifuged at a speed of 5000 rpm for 5
min and the microgels were recovered. The resulting microgels were thereafter washed
with acetone and dried at 28 °C.
Experimental design
A Central Composite Design with a = 1 was employed as per the standard protocol
(10). The amount of gelatin (X1) and the amount of glutaraldehyde (X2) were selected as
the factors whose effect will be studied on the response variables. Table I summarizes
the 13 experimental runs studied, their factor combinations, and the translation of the
coded levels to the experimental units employed during the study. Particle size, encap-
sulation efficiency (EE), diffusion coefficient (D), amount of mucin adsorbed per unit
mass (Qe) and the time taken to release 50 % of the drug (t50) were taken as response
variables.
Particle size and morphological studies
The particle size of the prepared drug loaded MGs (after drying) was measured us-
ing an optical microscope. The mean of 100 MGs was noted as particle size. All the read-
ings were the average of three trials ± SD. The shape and surface of microgels was exam-
ined by scanning electron microscopy (268D, Fei- Philips, USA).
Drug encapsulation efficiency
The MGs were evaluated for tramadol content by incubating 50 mg of microgels
with 5 mL of water for complete swelling. The swollen MGs were crushed in an agate
mortar with a pestle, and the homogeneous solution thus formed was sonicated for 5
min at 60 MHz. Tramadol was analyzed by a UV spectrophotometer (Systronics 2202, In-
dia) at 272 nm. Experiments were performed in triplicate and average values were con-
sidered for data treatment and calculations.
297
P. Kumar and I. Singh: Formulation and characterization of tramadol-loaded IPN microgels of alginate and gelatin: Optimization
using response surface methodology, Acta Pharm. 60 (2010) 295–310.
Diffusion coefficient
To determine the nature of water diffusion into the IPN hydrogels, initial swelling
data were fitted to the following exponential equation (11).
F = Mt/M = ktn
where F denotes the amount of water fraction at time t,Mt andM represent the amount
of water absorbed by the MGs at time t and at equilibrium, k is a characteristic constant
of the hydrogel, and n is a characteristic exponent of the mode of transport of the pene-
trate.
To calculate the diffusion coefficient of water moving through the IPN MGs, the fol-
lowing equation was employed (11):
D = pr2 (k/4)1/n
where, D is the diffusion coefficient of water (cm2 s–1) and r is the radius of dry gel.
Amount of mucin adsorbed (Qe)
Adsorption studies were carried out using the mucous glycoprotein assay method
(12), where a periodic acid/Schiff (PAS) colorimetric method was used to determine the
free mucin concentration in order to assess the amount of mucin adsorbed on the alginate-
-gelatin MGs and its effect on the assessment of mucoadhesive behavior of IPN microgels.
In vitro drug release
In vitro release of tramadol from the MGs was performed in USP XXIII apparatus I
(37 ± 0.5 °C, 50 rpm) using 0.1 mol L–1 HCl (pH 1.2, 500 mL) as dissolution medium for
the first 2 h and subsequently the rest of the release study was performed in phosphate
buffer (pH 7.4, 500 mL) for the following 12 h (13). A quantity of drug loaded microgels
equivalent to 100 mg of the drug for each batch was employed in all dissolution studies.
The aliquots, following suitable dilution, were analyzed spectrophotometrically at 272 nm.
The power law equation and Higuchi’s model were fitted to the kinetic data of drug
release. Power law model can be expressed as ft = Mt/M = kp tn (14). According to Hi-
guchi’s model, the fraction of the drug released is plotted vs. the square root of time
ft = Mt/M = kH t1/2 (15). In case of release studies, Mt corresponds to the amount of
drug released in time t,M

is the total amount of drug released after an infinite time, k is
a constant related to the structural and geometric properties of the drug release system
and n is the diffusional exponent.
Optimization data analysis and numerical optimization
Various RSM computations for the current optimization study were performed em-
ploying the Design-Expert software (Version 7.1.4, Stat-Ease Inc, USA). Polynomial mo-
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dels including interaction and quadratic terms were generated for all the response vari-
ables using the multiple linear regression analysis approach as represented in Eq. (1):
Y = â0 + â1X1 + â2X2 + â3X1X2 + â4X12 + â5X22 + â6X1X22 + â7 X12X2 (1)
where, â0 is the intercept representing the arithmetic average of all quantitative outcomes
of 13 runs, â1 to â7 are the coefficients computed from the observed experimental values,
Y, X1 and X2 are the coded levels of the independent variable(s). Numerical optimization
using the desirability approach was employed to locate the optimal settings of the for-
mulation variables to obtain the desired response.
Fourier transform infrared (FTIR) spectra
FTIR spectra were recorded on a Shimadzu 8400 infra-red spectrophotometer (Ja-
pan), using KBr, to confirm the formation of the IPN structure and also to find the chem-
ical stability of the drug in the formulation. FTIR spectra of the polymer mixture, drug-
-loaded microgels and plain tramadol were recorded in the range of 4000–400 cm–1.
Differential scanning calorimetry (DSC)
DSC study of pure tramadol, placebo microgels and drug loaded microgels was
conducted using a Model Q 10 (TA Systems, USA) thermal analyzer at a scanning rate of
10 °C min–1 in the temperature range of 15 to 350 °C under a nitrogen atmosphere (flow
rate 20 mL min–1).
The IPN microgels of sodium alginate and gelatine were prepared by the simple
emulsification phase separation technique. The SEM images show that the drug loaded
microspheres cross-linked with glutaraldehyde are spherical with a smooth surface as
shown in Fig. 1.
RESULTS AND DISCUSSION
FTIR
The characteristic peak of sodium alginate appearing at 819 cm–1 was not observed
in the spectra of microgels (Fig. 2). The absorption peak at 1624 cm–1 assigned to the
asymmetrical stretching vibration of –COO– groups of sodium alginate coupled with the
peaks at 1652 and 1558 cm–1 of gelatin shifted to 1634 cm–1 in placebo microgels suggest-
ing that new hydrogen bonds were formed between –COO– groups of sodium alginate
and –CONH2 groups of gelatin. Furthermore, the band of gelatin centered at about 3400
cm–1, which was the stretching vibration or –NH2 groups involved in both inter- and
intra-molecular hydrogen bonds (the band has a less intense component at 3400 cm–1
showing that there may be more than one type of feasible intermolecular hydrogen
bonds), broadened and coupled with –OH band of sodium alginate at 3450 cm–1, included
by the addition of sodium alginate to gelatin, implied the occurrence of hydrogen bonds
between –OH groups of sodium alginate and –NH2 groups of gelatin molecules. FTIR
spectra of pure drug and drug loaded microgels revealed the principle peaks at 1361
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cm–1 and 3312 cm–1 corresponding to the
amine stretch and –OH stretch, respectively.
The IR spectrum of microgels of tramadol
also presented the peaks characteristics of
pristine drug, indicating no interaction bet-
ween the drug and the polymer matrix.
DSC
DSC thermograms of placebo microgels,
drug-loaded microgels and pure tramadol
are displayed in Fig. 3. Placebo microgels,
drug-loaded microgels and pure tramadol
exhibited principal peaks at 79.37 and 215.45
°C, 79.90 and 216.32 °C and 183.84 and
269.77 °C, respectively. The thermograms
of IPN microgels containing tramadol are
almost identical to those of the placebo
IPN microgels (79.90 ~ 79.37 °C and 216.32
~ 215.45 °C, respectively). Also, the sharp
peak at 183.84 °C corresponding to trama-
dol was absent in the drug loaded microgels,
indicating probable formation of a drug-
-polymer inclusion complex, ensuing the
shielding of the characteristic peaks of tra-
madol. This inclusion complex might be a
factor affecting the release of the drug from
the cross-linked microgels.
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Fig. 2. FTIR spectra of: a) gelatin, b) sodium algi-
nate and c) placebo microgels.
Fig. 1. Scanning electron photomicrographs of
AG IPN microgels (X 500).
Mathematical modeling
Mathematical relationships generated using multiple linear regression analysis for
the studied response variables are expressed in Eqs. (2) – (6) in terms of coded factors:
particle size = 81.26 – 13.14X1 – 14.07X2 + 1.88X1X2 – 6.27X12 – 2.26X22 (2)
encapsulation efficiency = 75.12 + 4.45X1 + 4.21X2 – 0.58X1X2 + 2.61X12 + 0.17X22 (3)
diffusion coefficient = 0.22 – 0.15X1 – 0.11X2 + 0.87X1X2 + 0.66X12 + 0.039X22 –
– 0.035X1X22 – 0.043X12X2 (4)
Qe = 12.29 + 1.27X1 – 0.24X2 – 0.58X1X2 – 3.37X12 + 0.69X22 – 3.92X1X22 (5)
t50 = 118.57 + 32.73X1 + 18.83X2 + 5.53X1X2 + 9.38X12 + 2.16X22 (6)
The values obtained for the main effects of each factor in Eqs. (2), (3) and (4) reveal
that the amounts of gelatin (X1) and glutaraldehyde (X2) have a comparable effect on the
values of particle size, encapsulation efficiency and diffusion coefficient, whereas Eqs.
(5) and (6) reveal that the amount of gelatin (X1) has a more influential role for the re-
sponse variables Qe and t50.
Particle size
The response surface plot in Fig. 4a reveals that particle size varies in linear fashion
with the increase in the amount of each factor. Particle size decreases with an increase in
concentration of both X1 and X2 (Table I), which could be attributed to shrinkage of mi-
crogels caused by the high degree of cross-linking resulting in the formation of more
rigid network structures (16). Also, by increasing the amount of gelatin in the formula-
tion, a decrease in the size of microgels was observed, which may be attributed to the
formation of smaller droplets due to the increase in the viscosity of solution with increa-
sing concentration of gelatin during emulsification.
Encapsulation efficiency
The predictor equation generated [Eq. (3)] revealed that the levels of both X1 and X2
had a considerable positive effect on the encapsulation efficiency. The response surface
plot (Fig. 4b) illustrates that the encapsulation increased from 68.4 to 78.4 % and from
78.8 to 86.5 % at low and high levels of glutaraldehyde, respectively, as the gelatin
amount increased. It was evident from the 3-D plots that the encapsulation efficiency en-
hanced from 68.4 to 78.8 % and from 78.4 to 86.5 % at high and low levels of X1, respec-
tively, as the glutaraldehyde amount increased (Table I). This is due to the formation of a
rigid network that restricted leaching of the drug molecules during microgel prepara-
tion and hence caused retention of more drug molecules.
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Dynamic swelling kinetics
The swelling behaviour of MGs is linked to
the diffusion process, which in turn depends on
the nature of polymer network, cross-linking
density and elasticity of the polymeric network
(17). The negative influence of gelatin on the
diffusion coefficient is clearly demonstrated by
the response surface plots (Fig. 4c). All batches
showed good swelling initially (6–8 h), but
marked variation in swelling was observed in
all the batches after 24 h. Batches III, VI and IX
showed perfect swelling with no deformation
in the swelled matrices. The swelling kinetic
curves of the MGs are given in Fig. 5. The data
in this figure show that both the swelling ratio
and the swelling rate decreased with increasing
the amount of the crosslinker. The swelling ra-
tio of the MGs reduced due to a dense and
stiffer three-dimensional structure formed at
high glutaraldehyde concentration, which
might have prohibited the transport of water
molecules. However, the swelling capacity of
MGs decreased with increasing the amount of
gelatin in the matrix, which may be due to the
formation of a rigid IPN structure as a result of
increased entanglement of both polymeric
chains, as evident from the D values presented
in Table I. Diffusion coefficient falls in the range
from 0.07 to 0.74 × 10–6 cm2 s–1 and decreases
systematically with increasing amount of the
cross-linking agent as well as with increasing
amount of gelatin in the formulation.
Amount of mucin adsorbed (Qe)
The amount of mucin adsorbed was found to be increasing with an increase in
mucin concentration. The quadratic model generated [Eq. (5)] revealed that the levels of
gelatin and glutaraldehyde had a significant antagonistic influence on Qe without pro-
ducing any interaction. X1 was found to have a positive influence on the encapsulation
efficiency since it showed an increase with an increase in the level of gelatin. Further, the
amount of mucin adsorbed decreased with an increase in the amount of glutaraldehyde,
as evident from the response surface plots (Fig. 4d). In the case of batches I, II and III,
the amount of mucin adsorbed increased from 11.6 to 15.6 mg g–1, with an increase in
gelatin amount from 50 to 100 mg, which may be due to increasing availability of cations
in the matrix to interact with the negatively charged mucin. Further, in the case of
batches IV to VI and VII to IX, a ''region of maximum'' (12.2 and 13.6 mg g–1 for batches
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Fig. 3. DSC of: a) drug-loaded microgels,
b) placebo microgels and c) tramadol.
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V and VIII, respectively) for the amount of mucin adsorbed was observed at the inter-
mediate level of gelatin, as shown in the response surface. The lower value of Qe for
batches VI and IX may be attributed to the denser matrix owing to high cross-linking
density. Also, the presence of higher amounts of both gelatin and glutaraldehyde may
result in low swelling and low surface exposure. The polyampholytic structure of IPNs
may have an additional effect on tissue adhesion, due to the formation of transitional
physical crosslinks between cationic and anionic groups carried by network chains (18).
Besides, with a large amount of strong hydrogen-bonding groups (–OH, –COOH, –NH2)
on polymer chains, IPNs could adhere to the mucus layer through hydrogen bridges
(19). Thus, these studies indicate that there may be an increase in the residence time of
the formulation in the gastrointestinal tract by optimizing the amounts of X1 and X2 in
the microgels.
Adsorption isotherms
The data obtained were interpreted using Freundlich [Eq. (7)] or Langmuir [Eq. (8)]
equations describing the adsorption isotherms:
Cads = KCen (7)
Cads = aCe (b + Ce) (8)
where Cads is the concentration of mucin adsorbed at equilibrium and Ce is the concen-
tration of free mucin at equilibrium. Values of different constants were obtained from
the graphs of the above equations. For the Langmuir equation, 1/Cads was plotted
against 1/Ce to get the constants and for the Freundlich equation, log Cads was plotted
against log Ce to get the constants (12).
The equilibrium free concentration of mucin in solution was determined for the
measurement of mucin adsorption on MGs and the data so obtained were fitted with
Freundlich and Langmuir equations. Straight lines were obtained, and the constants
from these lines are listed in Table II. It was observed that R2 was significantly higher for
the Langmuir equation compared to the Freundlich equation in case of batches I to III.
This may be due to a more specific adsorption process where electrostatic interaction is
involved. However, in batches IV to XI, the R2 values vary on either side. The adsorption
of mucin to MGs is expected to be dominated by the electrostatic attraction between the
positively charged gelatin and negatively charged mucin as the amount of mucin ad-
sorbed increased with increasing mucin concentration.
In vitro drug release
Drug release from the IPN microgels was characterized by an initial phase of high
drug release (burst effect) resulting in the biphasic release pattern, which may be due to
peripheral attachment of the drug as a result of expulsion during microgel drying or
drug migration as a result of solvent drag during drying. The second-order polynomial
model generated in Eq. (6) revealed that gelatin levels have a positive and more pro-
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Fig. 4. Response surface plot showing the influence of amount of gelatin (X1) and glutaraldehyde
(X2) on: a) particle size, b) encapsulation efficiency, c) diffusion coefficient, d) amount of mucin ad-
sorbed, e) t50.
nounced influence on t50, since it improved on incorporation of higher amounts of gela-
tin. The response surface plots (Fig. 4e) illustrate that t50 increased from 82.6 to 115.9 min
and from 140.7 to 196.1 min at low and high levels of gelatin, respectively, as the
glutaraldehyde amount increased. Also, t50 increased from 82.6 to 140.7 min and from
115.9 to 196.1 min at low and high levels of glutaraldehyde, respectively, as the amount
of gelatin increased (Table I). Drug release rates are higher for microgels having a lower
amount of gelatin compared to those having a higher amount of gelatin. This further ex-
plains the formation of stiffer polymeric chain entanglements at higher amounts of gela-
tin in the IPN, thus reducing the rate of swelling as well as drug release. It was observed
that release rates depend upon the amount of GA used during cross-linking (Fig. 6.) Re-
lease was slower for formulations in which higher amount of glutaraldehyde was used
compared to those formulations in which lower amount of glutaraldehyde was present
in the matrix. This could be due to the fact that at higher cross-linking, the free volume
of the matrix will decrease, thereby hindering the transport of drug molecules through
the matrix. This could also reduce the rate of swelling as well as the rate of drug release
from the matrix. The release rate can be correlated with the diffusion coefficient (Table I),
which indicates that as the diffusion coefficient increases, the release rate also increases.
Release results were also analyzed using the empirical equation to estimate the re-
lease kinetic parameter, k (min–n) and the diffusional exponent, n (14). By applying the
least-squares estimation method to the release data at 95 % confidence level, the values
of k and n were determined. This data along with the values of correlation coefficient, R,
is presented in Table II.
Values of k decrease with increasing cross-link density (decreases from 8.63 to 8.03
and 4.77 min–1/3 in case of formulations I, IV and VII, respectively) as well as with in-
creasing amount of gelatin (decreases from 8.63 to 6.52 and 3.86 min–1/3 in case of for-
mulations I, II and III, respectively) in the IPN matrix. The decrease in kinetic constant
values reflects the decrease in the rate of drug release, which might be due to the domi-
nance of chain entanglement and subsequently low dissolution of polymer (as the amount
of glutaraldehyde is increased) and due to increasing viscosity of polymeric mixtures (as
the amount of gelatine is increased). On the other hand, values of n increased with in-
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Fig. 5. Swelling kinetics of various formula-
tion batches of AG-IPN microrogels. Error
bars represent the standard deviation (n = 3).
creasing cross-link density as well as with increasing amount of the gelatin in the IPN
matrix. It was observed that when the polymer concentration was increased, the drug
release rate decreased. This may be due to the large degree of swelling because of higher
polymer concentration. This is in accord with the solvent diffusion studies. The value of
n ranged from 0.4055 to 0.5754, suggesting that the drug release mechanism can vary
from Fickian to quasi-Fickian, which indicates that the drug release occurred through
diffusion in the hydrated matrix and polymer relaxation, depending upon variation in
the composition of the formulation. The slight deviation from the Fickian diffusion may
be due to the small amount of viscoelastic relaxation of the matrix during water penetra-
tion. The values of R2 for the different batches suggest that the release followed Higuchi
kinetics and hence was diffusion controlled. The IPN material synthesized in the present
research was found to form a potential hydrogel, which can find applications in the con-
trolled release of tramadol. The material has a good controlled release behavior and was
found to hold the encapsulated drug for a longer period of time (longer drug retaining
capacity).
Numerical optimization
A numerical optimization technique using the desirability approach was employed
to develop a new formulation with the desired responses. Upon comprehensive evalua-
tion of the feasibility search and subsequently exhaustive grid searches, the formulation
composition with gelatin concentration of 17.9 and the amount of glutaraldehyde 1.3 mL,
fulfilled maximum requirements of an optimum formulation because of better regula-
tion of the release rate and higher mucin adsorption. The optimized formulation was
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Table II. Estimated values of various exponents under adsorption and release studies
Code
Adsorption isotherms Release kinetics











I –0.113 0.153 0.818 172.62 1.644 0.781 3.941 0.985 0.4055 8.63 0.978
II –0.029 0.012 0.947 93.626 1.074 0.942 4.041 0.991 0.4514 6.52 0.991
III –0.021 0.009 0.941 94.156 1.143 0.928 3.881 0.989 0.5257 3.86 0.957
IV –0.103 0.027 0.956 103.56 0.839 0.972 3.909 0.991 0.4138 8.03 0.988
V –0.039 0.014 0.945 93.907 1.028 0.949 3.848 0.991 0.4503 5.93 0.973
VI –0.061 0.019 0.954 92.982 0.932 0.965 3.890 0.987 0.5725 3.02 0.953
VII –0.049 0.016 0.976 151.04 0.587 0.972 4.217 0.994 0.5016 4.77 0.982
VIII –0.110 0.027 0.963 111.60 0.832 0.925 3.728 0.989 0.5264 3.93 0.977
IX –0.241 0.057 0.948 119.64 0.713 0.977 3.668 0.994 0.5754 2.46 0.973
a Cads = a Ce (b + Ce)
b Cads = KCen
c ft = Mt/M = kH t1/2
d ft = Mt/M = kP tn
evaluated for various dependent variables. The response values were calculated and
compared to the corresponding predicted values. Table III lists the values of the obser-
ved responses and those predicted by mathematical models along with the percentage
prediction errors. The prediction error for the response parameters ranged between 3.1
and 3.6 % with the value of absolute error of 3.3 ± 0.8 %. Drug release from the opti-
mized formulation was found to follow Fickian diffusion and was characterized by the
Higuchi kinetic model.
CONCLUSIONS
An IPN structure was prepared by chemically cross-linking sodium alginate with
gelatin using glutaraldehyde. FTIR spectroscopy and DSC confirmed the formation of
the IPN structure and probable formation of a drug-polymer inclusion complex, respec-
tively. The dependent variables viz. geometric mean diameter, encapsulation efficiency,
diffusion coefficient, amount of mucin adsorbed per unit mass and drug release could
be modulated by varying the critical formulation variables, namely, the amounts of gela-
tin and glutaraldehyde. Mucin adsorption capacity of microgels was determined and
adsorption isotherms of the system were fitted in Langmuir and Freundlich equations.
High degree of prognosis obtained using the response surface methodology corrobo-
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Encapsulation efficiency (%) Maximize 79.96 ± 2.06 77.38 3.2
Diffusion coefficient × 106 (cm2 s–1) Minimize 0.139 ± 0.002 0.134 3.6
Qe (mg g
–1) Maximize 12.85 ± 0.08 13.27 3.2
t50 (min) Maximize 177.21 ± 26.15 183.90 3.6
Absolute error 3.3 ± 0.8 %




















Fig. 6. In vitro release profile of formu-
lations depicting the effect of polymer
ratio. Error bars represent the standard
deviation (n = 3).
rates that a 2-factor central composite design is quite efficient in optimizing drug deli-
very systems that exhibit nonlinearity in response(s). Incorporation of gelatin along with
alginate in the IPN structure was found to enhance mucin adsorption and significantly
reduce gel erosion, which makes the AG-IPN-MGs suitable candidates for the controlled
release mucoadhesive drug delivery system of tramadol.
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S A @ E T A K
Izrada i karakterizacija IPN alginatnih i `elatinskih mikrogelova s tramadolom:
Optimiranje pomo}u metode odzivnih povr{ina
PRADEEP KUMAR i INDERBIR SINGH
Interpenetriraju}i umre`eni polimerni (IPN) alginatno-`elatinski (AG) mikrogelovi
(MG) tramadola pripravljeni su metodom umre`avanja koriste}i glutaraldehid kao sred-
stvo za umre`avanje. Pripravci su optimirani pomo}u odzivnih povr{ina. Kompozitini
dizajn s dva faktora na tri nivoa upotrijebljen je za procjenu kriti~nih formulacijskih va-
rijabli: pra}en je utjecaj koli~ine `elatine (X1) i glutaraldehida (X2) na prosje~nu veli~inu
~estica, sposobnost kapsuliranja, koeficijent difuzije (D), koli~inu adsorbiranog mucina
po jedinici mase (Qe) i vrijeme potrebno za osloba|anje 50 % lijeka (t50). Dobiveni su
mikrogelovi prosje~ne veli~ine ~estica od 44,31 do 102,41 m, a maksimalno postignuto
vezanje lijeka bilo je 86,5 %. Mikrogelovi su karakterizirani FT-IR spektroskopijom i dife-
rencijalnom pretra`nom kalorimetrijom (DSC). Ravnote`ne i dinami~ke studije bubrenja
provedene su u fosfatnom puferu pH 7,4. Koeficijenti difuzije i eksponenti za transport
vode odre|eni su pomo}u empirijske jednad`be. Mukoadhezivna svojstva MGs evalui-
rana su u vodenoj otopini mjerenjem adsorpcije mucina na mikrogelove. Konstruirane
su adsorpcijske izoterme i uspore|ene s Freudlichovim i Langmuirovim jednad`bama.
Pokusi in vitro pokazuju da osloba|anje ljekovite tvari ovisi o stupnju umre`enja i koli-
~ini `elatine upotrijebljene u pripravi IPN. Vrijednosti osloba|anja uvr{tene su u jednad-
`bu zakona potencije i u Higuchijev model kako bi se izra~unali razni parametri prije-
nosa lijeka; n vrijednosti bile su izme|u 0,4055 i 0,5754, {to ukazuje na to da osloba|anje
varira od Fickovog do kvazi-Fickovog, ovisno o sastavu pripravka.
Klju~ne rije~i: natrijev alginat, `elatina, mikrogel, IPN, difuzija, adsorpcija na sluznici
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